
Monocare 1gm Injection
Marketer
Mac Laboratories Ltd
Salt Composition
Ceftriaxone (1gm)
Overview Monocare 1gm Injection
Cephalosporin-based antibiotic Cefixime 1g Injection combats bacterial infections throughout the body. Its applications encompass diverse sites, including the central nervous system (meningitis), respiratory system (pneumonia), ears, urinary tract, integumentary system, musculoskeletal system, bloodstream, and cardiovascular system. Prophylactic use is also indicated pre-operatively. Administered intravenously or intramuscularly by a medical professional, dosage is determined individually. Consistent, evenly spaced doses, as directed, are crucial for effective treatment; premature discontinuation risks relapse or infection exacerbation. Common adverse reactions may include gastrointestinal upset (diarrhea), dermatological reactions (rash), altered liver function markers, and hematological changes (eosinophilia, leukopenia, thrombocytopenia). Transient injection site erythema or discomfort is possible. While usually mild, persistent or bothersome effects warrant medical attention. Prior to treatment, disclose any antibiotic allergies, hepatic or renal impairment, and all concomitant medications to your physician, as drug interactions are possible.
Primary Ingredients of Monocare 1gm Injection
No information provided. Please provide the text you wish me to rewrite.
Uses of Monocare 1gm Injection
Managing bacterial illnesses
Major Benefits of Monocare 1gm Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Monocare 1gm Injection:
- Diarrhea
- Abnormal liver function tests
- Rash
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count
- Low blood platelets
How to use Monocare 1gm Injection:
This medication will be administered by your healthcare provider; self-medication is strongly discouraged.
How Monocare 1gm Injection works:
Cefuroxime 1g injection, an antibacterial agent, eradicates bacteria by inhibiting the synthesis of their essential protective cell wall.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Monocare 1gm Injection.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Monocare 1gm Injection is considered safe. The majority of research indicates minimal or no harm to the fetus.
Breast feedingCAUTION
Administering Monocare 1gm Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Monocare 1gm Injection can induce drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
For patients with kidney disease, Monocare 1gm Injection is considered safe, and no dosage alteration is necessary. Nevertheless, disclosure of any pre-existing kidney condition to your physician is advised.
LiverCAUTION
For patients with severe hepatic impairment, Monocare 1gm Injection requires careful administration and potential dose modification. Individuals with mild to moderate liver disease, however, do not typically require dose alteration of Monocare 1gm Injection. Physician consultation is advised.
What if you forget to take Monocare 1gm Injection :
Omitting a scheduled dose of Monocare 1gm Injection warrants immediate physician consultation.
Facts to Know About Monocare 1gm Injection
| Label | Value |
|---|---|
| Chemical Type | Extended-Spectrum Cephalosporins (Generations 3 & 4) |
| Developing Habits | No. |
| Type of Treatment | Antimicrobial Agents |
